[
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The result showed that the expression of CAMP was upregulated significantly in the cancer tissues compared to the normal tissues (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Then, we further validated in our cohort that the expression level of CAMP was higher in breast cancer patients’ tissues (T) when compared to their paired normal tissues (TN) and normal control tissues (NC) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Additionally, we revealed CAMP was upregulated in breast cancer patients’ plasma when compared with normal individuals (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The concentration of human antibacterial peptide LL-37 was significantly higher in breast cancer patients than in normal individuals and ductal carcinoma in situ (DCIS) cases (Figure 1D).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel D",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among the breast cancer patients, we observed a decreased LL-37 level in post-operative blood samples (Figure 1E).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CAMPConfers Oncogenic Roles in Breast Cancer\nTo further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP inhibition significantly decreased cell viability in breast cancer cells. (A) CAMP mRNA expression and protein level (B) in breast cancer cell lines; qRT-PCR (C) and Western blotting results (D) showed that CAMP was significantly suppressed by siRNA; (E) secreted CAMP peptide level in cell culture medium was detected by ELISA in breast cancer cells; (F) MTT assay after CAMP siRNA in breast cancer cells; (G) CAMP receptor specific antagonist, A438079inhibited cell proliferation. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCAMP knockdown altered cell cycle progression and apoptosis. (A) Significantly increased G1 phase arrest was observed in both cell lines after CAMP knockdown (negative control: parental breast cancer cells); (B) early apoptotic cells were induced upon CAMP siRNA (negative control: parental breast cancer cells); (C) Western blot result of cleaved caspase-3 in breast cancer cells after CAMP knockdown. * p < 0.05, ** p < 0.01, *** p < 0.001 indicates statistically different.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To further elucidate the functional implication of CAMP in breast cancer, we investigated the expression of CAMP in different breast cancer cell lines (MDA-MB-231: triple-negative breast cancer; MCF-7: estrogen receptor-positive; SK-BR-3: HER2-positive; T47D: estrogen receptor-positive) by qRT-PCR (Figure 2A) and Western blotting (Figure 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Knockdown of CAMP decreased mRNA expression, protein level, and secreted CAMP protein (Figure 2C–E).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "MTT assay result confirmed that siCAMP led to significant growth inhibition in MCF-7 and T47D cell lines (Figure 2F) but not in SK-BR-3 (data not shown).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel F",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Treatment with CAMP receptor-specific antagonist, A438079, dose-dependently inhibited breast cancer cell growth (Figure 2G).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel G",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cell cycle analysis suggested a significant G1 phase arrest in CAMP-deficient cells (Figure 3A).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "CAMP knockdown also led to robust increase in early apoptotic cells (Figure 3B) along with increased cleaved Caspase 3 expression (Figure 3C).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Both cell migration ability (Figure 4A) and invasiveness (Figure 4B) were suppressed upon CAMP knockdown in T47D cells, which may be due to increased CDH1 and decreased ALDH activity (Figure 4C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel C",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel B",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To consolidate this result, we developed stable CAMP overexpressing MDA-MB-231 cells (Figure 4E) and found that ectopic CAMP expression enhanced migration and invasion ability (Figure 4F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel F",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "Panel E",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "CAMP is Essential in Tumor Cells-M2 Macrophage Microenvironment\nTHP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "THP-1 cells were differentiated into macrophage (M0) by incubation with PMA for 72 h (Figure 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "CD68, which is a marker for macrophages, were increased upon PMA treatment by flow cytometry analysis (Figure 5B).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Immunofluorescence identified CD68 expression was co-expressed with CAMP in macrophages (Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "After macrophages were co-cultured with T47D cells in the transwell system, immunofluorescence staining showed increased M2 marker (ARG-1) and CAMP immunofluorescence intensity (Figure 5D), while expression of M1 marker (iNOS) was decreased (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel D",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the CAMP-deficient macrophage group (A438079 pre-treated group), M2 marker ARG-1 expression was decreased when compared to the control group co-culture with breast cancer (BC) cells (Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In addition, expressions of CAMP M2 marker (CD163), P2X7 (CAMP-specific receptor), and IGF-1R increased in a time-dependent manner (Figure 5G).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Co-culture of breast cancer cells with M2 macrophages promoted cancer cell proliferation and was abated in the cancer cells co-cultured with CAMP-deficient macrophages (Figure 6A) with increased CAMP and P2X7 expressions (Figure 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "IF staining revealed CAMP signal intensity was upregulated while CDH1 intensity was decreased in the presence of M2 macrophages (Figure 6C).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The Western blotting result showed CAMP protein expression increased in both macrophages and breast cancer cells after co-culture for 5 days (Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMP peptide concentration was increased in medium during co-culture of breast cancer cells and macrophages (Figure 6E).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel E",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The induced M2 marker (CD163 and ARG-1) expressions in macrophages during co-culture with T47D were impeded by CAMP knockdown or antagonist treatment, respectively (Figure 6F,G).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel F",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "CAMPInhibition Reduced Tumor Growth In Vivo\nTo further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "To further investigate the role of CAMP on tumor growth, we developed a CAMP-stable overexpressing breast cancer cell line (Figure 7A).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel A",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Secreted CAMP protein level was upregulated in CAMP overexpressing cells when compared to the control group (Figure 7B).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel B",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "MTT and colony formation assay enhanced cell growth ability in CAMP overexpressing cells when compared to vector control (Figure 7C,D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel C",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the animal study, we found that mice with CAMP overexpressing cells had larger tumor volume than vector control, suggesting an oncogenic role of CAMP in vivo (Figure 7E).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel E",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Additionally, mice with cancer cells + macrophages exhibited the largest tumor volume while the CAMP receptor antagonist inhibited the tumor growth (Figure 7F).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel F",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Besides, human-specific CD68 was barely seen in T47D and T47D + A438079 groups (Figure 7G).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      },
      {
        "figure_number": "Figure 7",
        "panel": "Panel G",
        "figure_key": "figure_7"
      }
    ]
  }
]